Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kimyagaran Emrouz, often operating under the trade name Kimyagaran Lead Sciences, is a leading Iranian chemical and pharmaceutical company established in 1995. The company specializes in the production of ethoxylated products and a wide range of active pharmaceutical ingredients (APIs), including being one of the largest regional producers of Paracetamol and Metformin. Their business model encompasses the entire value chain from industrial chemical manufacturing to the production of finished dosage forms. Headquartered in Tehran with major manufacturing facilities in the Shazand Industrial Zone, the company serves both domestic and international markets in the pharmaceutical, detergent, and cosmetic industries. Kimyagaran is publicly traded on the Tehran Stock Exchange and is recognized for its significant R&D investment in chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kimyagaran Lead Sciences.